Welcome and opening remarks

Javier Díez
Francisco Fernández-Avilés
Coordinadores del Simposio.

José María Segovia de Arana
Consejo Científico.
Fundación Ramón Areces.

FROM GENES TO CARDIOVASCULAR RISK
Genotype-phenotype interactions in primary cardiomyopathies

Steven Marston 
Imperial College London.
National Heart and Lung Institute, Cardiac Medicine.
Londres. U.K.

Pathways linking insulin resistance with cardiovascular risk

Ele Ferrannini
Departamento de Medicina Interna.
Università di Pisa. Italy.

Round table
From mutations to imaging in primary cardiomyopathie

Lorenzo Montserrat
Servicio de Cardiología.
Complejo Hospitalario Juan Canalejo. La Coruña. Spain

Diabetes mellitus, vascular inflammation and atherosclerosis. Old and new models for translational research

María Teresa Tejerina
Departamento de Farmacología.
Facultad de Medicina. Universidad Complutense. Madrid. Spain

Relationship of insulin resistance with oxidative stress in the metabolic syndrome

Guillermo Zalba
Área de Ciencias Cardiovasculares.
Centro de Investigación Médica Aplicada.
Universidad de Navarra. Pamplona. Spain

Translation of molecular advances in the field of cardiovascular diseases to the public health system

Rafael Gabriel
Unidad de Epidemiología.
Hospital Universitario La Paz. Madrid. Spain

Identifying new players in the atherogénesis of atherosclerosis

Jesús Egido
Laboratorio de Patología Vascular y Renal.
Fundación Jiménez Díaz-Universidad Autónoma de Madrid. Spain

Molecular control of left ventricular growth and failure

Gerald W. Dorn
Center for Molecular Cardiovascular Research.
University of Cincinnati. USA.

Novel therapeutic approaches for chronic heart failure: From bench to bedside

Javier Díez

Round Table
Characterization of the spatio-temporal properties of atrial fibrillation: A quest for a pathophysiologic treatment of atrial fibrillation

Felipe Atienza
Sección de Electrofisiología. Servicio de Cardiología.
Hospital General Universitario Gregorio Marañón. Madrid. Spain.

The missing-link from myocardial structure to ventricular pump function: new insights from cardiovascular imaging

Javier Bermejo
Sección de Cardiología No Invasiva. Servicio de Cardiología.
Hospital General Universitario Gregorio Marañón. Madrid. Spain.

Mechanisms of myocardial protection: From molecules to pharmacological compounds

David García Dorado
Laboratorio de Cardiología Experimental. Servicio de Cardiología.
Hospital Vall d'Hebron.
Barcelona. Spain.

ADVANCES IN CORONARY HEART DISEASE
Coronary microvascular dysfunction in acute coronary syndromes. Pathophysiology and clinical implications

Paolo Camicci 
MRC Clinical Sciences Centre.Imperial College.
Londres. UK.

Round Table
Pathophysiological aterogénes of NO-induced post-translational modifications

Santiago Lamas
Centro de Investigaciones Biológicas.
CSIC e Instituto "Reina Sofía" de Investigaciones Nefrológicas. Madrid. Spain.

Genetic predisposition to atherogenes and ischemic events

José Manuel Soria Fernández
Unidad de Trombosis y Hemostasia.
Departamento de Hematología.
Hospital de la Santa Cruz y San Pablo.
Universidad Autónoma de Barcelona. Spain.

Atherosclerotic plaque thrombogenic potential modulation by endothelial protein C receptor

José Hermida 
Área de Ciencias Cardiovasculares. Centro de Investigación Médica  Aplicada.
Universidad de Navarra. Pamplona. Spain.

THE FUTURE IN THE TREATEMENT OF CARDIOVASCULAR DISEASES
From the cell to the tissue. Cell-based prevention, treatment and cure for cardiovascular diseases

Doris A.Taylor
Center for Cardiovascular Repair. Department of Physiology. College of Medicine.
University of Minnesota.
Minneapolis. USA.

Progress in imaging of atherothrombosis

Valentín Fuster
Mount Sinai School of Medicine.
Nueva York. USA.

Angiogenic mechanisms in ischemic diseases: Therapeutic opportunitiess

Massimiliano Mazzone 
Centre for Transgene Technology and Gene Therapy.
Flanders Interuniversity Institute for Biotehcnology.
K.U.Leuven. Belgium.

How research and technological developments are repairing the failure of natural heart development

Joaquim Miró Lajara
Congenital Cardiac Diseases. Hospital Sainte Justine.
Montreal. Canada.

Closing remarks and farewell